Hisham Hegab
MD
GU Medical Oncology Specialist
👥Biography 个人简介
Dr. Hisham Hegab is a GU oncologist who has contributed to the characterization and management of enfortumab vedotin toxicities including peripheral neuropathy and skin reactions in urothelial cancer patients. His work supports safe clinical implementation of Nectin-4-directed ADC therapy in diverse patient populations. He is an advocate for expanding access to ADC-based urothelial cancer treatments in the MENA region.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Hisham Hegab 的研究动态
Follow Hisham Hegab's research updates
留下邮箱，当我们发布与 Hisham Hegab（National Cancer Institute, Cairo University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment